| Net Cash Provided by (Used in) Operating Activities |
$28,360 |
USD |
62% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
467,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
318,890,559 |
shares |
5717% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$230,470 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$993,386 |
USD |
80% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$993,386 |
USD |
80% |
Q4 2024 |
FY 2024 |
| Depreciation |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$441,851 |
USD |
65% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$8,212,004 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$137,393 |
USD |
-57% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |